Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015

Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2585CTIDB
  • |
  • Pages: 84
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Follicular Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Follicular Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Follicular Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Follicular Thyroid Cancer 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Follicular Thyroid Cancer 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Follicular Thyroid Cancer Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Bayer AG 31

Clinical Trial Overview of Bayer AG 31

Eisai Co., Ltd. 32

Clinical Trial Overview of Eisai Co., Ltd. 32

Exelixis, Inc. 33

Clinical Trial Overview of Exelixis, Inc. 33

AstraZeneca PLC 34

Clinical Trial Overview of AstraZeneca PLC 34

Clinical Trial Overview of Top Institutes / Government 35

National Cancer Institute 35

Clinical Trial Overview of National Cancer Institute 35

University of Washington 37

Clinical Trial Overview of University of Washington 37

University of Kentucky 38

Clinical Trial Overview of University of Kentucky 38

University of California, San Francisco 39

Clinical Trial Overview of University of California, San Francisco 39

MedStar Washington Hospital Center 40

Clinical Trial Overview of MedStar Washington Hospital Center 40

Mashhad University of Medical Sciences 41

Clinical Trial Overview of Mashhad University of Medical Sciences 41

Memorial Sloan Kettering Cancer Center 42

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 42

University of Colorado 43

Clinical Trial Overview of University of Colorado 43

The National Institute of Diabetes and Digestive and Kidney Diseases 44

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44

University of Michigan 45

Clinical Trial Overview of University of Michigan 45

Five Key Clinical Profiles 46

Appendix 81

Abbreviations 81

Definitions 81

Research Methodology 82

Secondary Research 82

About GlobalData 83

Contact Us 83

Disclaimer 83

Source 84

List of Figures

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 82

List of Tables

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Follicular Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 31

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 32

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 33

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 34

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 35

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 37

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 38

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 39

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MedStar Washington Hospital Center, 2015* 40

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 41

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 42

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 43

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 44

Follicular Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Follicular Thyroid Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Follicular Thyroid Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161400
Site License
USD 5000 INR 322800
Corporate User License
USD 7500 INR 484200

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com